ValuEngine lowered shares of IntriCon (NASDAQ:IIN) from a strong-buy rating to a buy rating in a research report released on Friday.
IIN has been the topic of a number of other research reports. TheStreet cut shares of IntriCon from a b rating to a c+ rating in a research note on Monday, October 1st. BidaskClub cut shares of IntriCon from a strong-buy rating to a buy rating in a research note on Tuesday, November 13th. Zacks Investment Research raised shares of IntriCon from a hold rating to a buy rating and set a $50.00 target price on the stock in a research note on Wednesday, October 24th. Stifel Nicolaus upped their target price on shares of IntriCon from $65.00 to $70.00 and gave the company a buy rating in a research note on Friday, September 21st. Finally, Dougherty & Co cut shares of IntriCon from a buy rating to a neutral rating and set a $12.00 target price on the stock. in a research note on Tuesday, September 11th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company currently has an average rating of Buy and a consensus target price of $48.50.
Shares of IIN traded down $2.07 during trading hours on Friday, reaching $31.09. 148,501 shares of the company traded hands, compared to its average volume of 186,370. The firm has a market capitalization of $286.53 million, a P/E ratio of 107.21, a P/E/G ratio of 3.84 and a beta of 0.95. IntriCon has a 1-year low of $16.70 and a 1-year high of $76.80.
Institutional investors have recently modified their holdings of the business. First Mercantile Trust Co. bought a new stake in IntriCon during the third quarter worth about $159,000. GSA Capital Partners LLP acquired a new stake in shares of IntriCon during the 2nd quarter worth about $226,000. Rhumbline Advisers acquired a new stake in shares of IntriCon during the 2nd quarter worth about $232,000. CAPROCK Group Inc. acquired a new stake in shares of IntriCon during the 3rd quarter worth about $251,000. Finally, Los Angeles Capital Management & Equity Research Inc. acquired a new stake in shares of IntriCon during the 3rd quarter worth about $270,000. 59.51% of the stock is currently owned by hedge funds and other institutional investors.
IntriCon Company Profile
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.
Recommended Story: What are the Benefits of Index Funds?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.